Illinois State is committed to providing a safe environment for students attending the University. Where the health risk to students may be increased due to participation in an academic program, the University will require that all possible steps be taken to safeguard the health of students.
All students enrolled in certain academic courses, or programs (e.g., nursing) with an increased risk of contracting Hepatitis-B shall be immunized against this disease. The department chairperson is responsible for notifying students of this requirement.
In some cases, students may be permitted to decline the Hepatitis-B vaccine. To obtain more information about this option students should contact their Department Chairperson.
Students enrolled in programs identified and designated with the approval of the dean of the applicable college as presenting an increased risk of contracting Hepatitis-B shall be immunized against Hepatitis-B.
Students required to be immunized will be required to receive the series of three injections of Hepatitis-B vaccine (presently over a period of six months). At least two injections of Hepatitis-B vaccine must be received prior to any potential exposure in courses and/or field experiences. The student may also show proof of immunity by providing a Hepatitis-B lab antibody titer.
Students will be required to pay for the Hepatitis-B vaccine plus the cost of administration. If funds are available through the University, they may be used to pay for all or a portion of the costs.
Students may receive the vaccine or lab titer at the Student Health Service or from another health care provider of their choice.